Erez Israeli

Erez Israeli is the Chief Executive Officer of Dr. Reddy’s Laboratories Ltd., an Indian multinational pharmaceutical company. Under his leadership, the company has focused on expanding its generic drug portfolio, including efforts to introduce generic versions of key therapies like semaglutide in major markets. Recently, he addressed the company's plans and challenges regarding regulatory approvals for semaglutide, a popular diabetes and weight-loss medication.